202 related articles for article (PubMed ID: 24330857)
1. Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions.
Bastian AR; Contarino M; Bailey LD; Aneja R; Moreira DR; Freedman K; McFadden K; Duffy C; Emileh A; Leslie G; Jacobson JM; Hoxie JA; Chaiken I
Retrovirology; 2013 Dec; 10():153. PubMed ID: 24330857
[TBL] [Abstract][Full Text] [Related]
2. Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators.
Zhang S; Holmes AP; Dick A; Rashad AA; Enríquez Rodríguez L; Canziani GA; Root MJ; Chaiken IM
Retrovirology; 2021 Oct; 18(1):31. PubMed ID: 34627310
[TBL] [Abstract][Full Text] [Related]
3. Targeting cell surface HIV-1 Env protein to suppress infectious virus formation.
Bastian AR; Ang CG; Kamanna K; Shaheen F; Huang YH; McFadden K; Duffy C; Bailey LD; Sundaram RVK; Chaiken I
Virus Res; 2017 May; 235():33-36. PubMed ID: 28390972
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virions.
Qi Q; Wang Q; Chen W; Du L; Dimitrov DS; Lu L; Jiang S
Emerg Microbes Infect; 2017 Jun; 6(6):e59. PubMed ID: 28634358
[TBL] [Abstract][Full Text] [Related]
5. The Polar Region of the HIV-1 Envelope Protein Determines Viral Fusion and Infectivity by Stabilizing the gp120-gp41 Association.
Lu W; Chen S; Yu J; Behrens R; Wiggins J; Sherer N; Liu SL; Xiong Y; Xiang SH; Wu L
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651369
[TBL] [Abstract][Full Text] [Related]
6. Disulfide Sensitivity in the Env Protein Underlies Lytic Inactivation of HIV-1 by Peptide Triazole Thiols.
Bailey LD; Kalyana Sundaram RV; Li H; Duffy C; Aneja R; Rosemary Bastian A; Holmes AP; Kamanna K; Rashad AA; Chaiken I
ACS Chem Biol; 2015 Dec; 10(12):2861-73. PubMed ID: 26458166
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation.
Rosemary Bastian A; Nangarlia A; Bailey LD; Holmes A; Kalyana Sundaram RV; Ang C; Moreira DR; Freedman K; Duffy C; Contarino M; Abrams C; Root M; Chaiken I
J Biol Chem; 2015 Jan; 290(1):529-43. PubMed ID: 25371202
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
9. Mutations That Increase the Stability of the Postfusion gp41 Conformation of the HIV-1 Envelope Glycoprotein Are Selected by both an X4 and R5 HIV-1 Virus To Escape Fusion Inhibitors Corresponding to Heptad Repeat 1 of gp41, but the gp120 Adaptive Mutations Differ between the Two Viruses.
Zhuang M; Vassell R; Yuan C; Keller PW; Ling H; Wang W; Weiss CD
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894471
[TBL] [Abstract][Full Text] [Related]
10. Impact of HIV-1 Membrane Cholesterol on Cell-Independent Lytic Inactivation and Cellular Infectivity.
Kalyana Sundaram RV; Li H; Bailey L; Rashad AA; Aneja R; Weiss K; Huynh J; Bastian AR; Papazoglou E; Abrams C; Wrenn S; Chaiken I
Biochemistry; 2016 Jan; 55(3):447-58. PubMed ID: 26713837
[TBL] [Abstract][Full Text] [Related]
11. Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.
Ang CG; Carter E; Haftl A; Zhang S; Rashad AA; Kutzler M; Abrams CF; Chaiken IM
Microorganisms; 2021 Jun; 9(6):. PubMed ID: 34204725
[TBL] [Abstract][Full Text] [Related]
12. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
[TBL] [Abstract][Full Text] [Related]
13. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure.
Fischer PB; Karlsson GB; Dwek RA; Platt FM
J Virol; 1996 Oct; 70(10):7153-60. PubMed ID: 8794362
[TBL] [Abstract][Full Text] [Related]
14. Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46.
Hermann FG; Egerer L; Brauer F; Gerum C; Schwalbe H; Dietrich U; von Laer D
J Virol; 2009 May; 83(10):4844-53. PubMed ID: 19279116
[TBL] [Abstract][Full Text] [Related]
15. A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.
Murray EJ; Leaman DP; Pawa N; Perkins H; Pickford C; Perros M; Zwick MB; Butler SL
J Virol; 2010 Jul; 84(14):7288-99. PubMed ID: 20427524
[TBL] [Abstract][Full Text] [Related]
16. Anti-HIV-1 activity of cellulose acetate phthalate: synergy with soluble CD4 and induction of "dead-end" gp41 six-helix bundles.
Neurath AR; Strick N; Jiang S; Li YY; Debnath AK
BMC Infect Dis; 2002 Apr; 2():6. PubMed ID: 11983022
[TBL] [Abstract][Full Text] [Related]
17. An inducible HIV type 1 gp41 HR-2 peptide-binding site on HIV type 1 envelope gp120.
Alam SM; Paleos CA; Liao HX; Scearce R; Robinson J; Haynes BF
AIDS Res Hum Retroviruses; 2004 Aug; 20(8):836-45. PubMed ID: 15320988
[TBL] [Abstract][Full Text] [Related]
18. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer.
Alsahafi N; Debbeche O; Sodroski J; Finzi A
PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367
[TBL] [Abstract][Full Text] [Related]
19. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
[TBL] [Abstract][Full Text] [Related]
20. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
